Company filings, made visual.

Find a company. Follow its revenue through costs and profit.

Market

Find a company or ticker

Coverage includes separate ticker and security records; counts are not unique companies.

Mankind Pharma

MANE

Filing: SEC 10-Q
Period: Three months ended March 31, 2026
Basis: Editorial filing; Read original SEC 10-Q ↗

Sankey diagram of Mankind Pharma. A complete text table follows the diagram.

Mankind Pharma development platform

The reviewed filing reports no current product sales, so the visual uses an indexed platform node rather than fabricated revenue.

Swipe to explore

Source & review

Read original SEC 10-Q ↗

SEC accession: 0001827635-26-000019
Filed: Date not recorded
Reviewed: Date not recorded
Status: Individual filing review complete

How to read these figures

Labels and displayed flow values are reported filing values or exact disclosed subtotals.

Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.

Values are in millions of USD unless otherwise noted.

View accessible tables

Financial categories · Three months ended March 31, 2026 · Millions of USD
Category	Stage	Value	Notes
Total reported revenue	1	$1M	Reported filing total
Pharmaceutical development platform	2	$1M	Indexed view; no current product sales

Financial flows · Millions of USD
From	To	Value
Total reported revenue	Pharmaceutical development platform	$1M